Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 119 |  VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 503.39 USD | -0.44% | -0.66% | -3.93% | +20.05% | 127.59 B USD | ||
| 211 |  MRNA Moderna, Inc. - Common Stock | 197.20 USD | +0.37% | +4.38% | +40.56% | +603.78% | 78.73 B USD | ||
| 218 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 739.50 USD | -0.35% | +0.64% | -8.00% | +29.96% | 76.14 B USD | ||
| 306 |  ARGX argenx SE - American Depositary Shares | 817.80 USD | -11.92% | -12.63% | -17.53% | +2.67% | 50.61 B USD | ||
| 369 |  RVMD Revolution Medicines, Inc. - Common Stock | 188.10 USD | -6.36% | -8.64% | -8.69% | +239.53% | 40.32 B USD | ||
| 446 |  ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 224.53 USD | +0.05% | -2.82% | -12.46% | -50.22% | 30.04 B USD | ||
| 506 |  RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.21 USD | -0.97% | -2.46% | -7.24% | +50.86% | 25.10 B USD | ||
| 512 |  ROIV Roivant Sciences Ltd. - Common Shares | 34.23 USD | -1.50% | -3.58% | -17.30% | +86.95% | 24.73 B USD | ||
| 530 |  INCY Incyte Corporation - Common Stock | 112.73 USD | -0.63% | -3.76% | -9.38% | +31.77% | 22.85 B USD | ||
| 531 |  UTHR United Therapeutics Corporation - Common Stock | 532.78 USD | -2.24% | -6.76% | +6.99% | +18.44% | 22.85 B USD | ||
| 539 |  BNTX BioNTech SE - American Depositary Shares | 92.06 USD | -3.35% | -4.89% | -6.54% | -13.34% | 22.09 B USD | ||
| 551 |  INSM Insmed Incorporated - Common Stock | 100.61 USD | -1.11% | -7.29% | -18.86% | -37.91% | 21.97 B USD | ||
| 684 |  EXEL Exelixis, Inc. - Common Stock | 59.02 USD | +0.99% | +1.86% | +2.64% | +51.18% | 14.62 B USD | ||
| 700 |  JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 222.45 USD | -3.78% | -4.53% | -6.70% | +58.89% | 14.44 B USD | ||
| 711 |  ASND Ascendis Pharma A/S - American Depositary Shares | 222.63 USD | -2.53% | -1.93% | -17.15% | +8.56% | 13.80 B USD | ||
| 723 |  SMMT Summit Therapeutics Inc. - Common Stock | 17.18 USD | -4.29% | +3.00% | -5.29% | -13.49% | 13.71 B USD | ||
| 752 |  CORT Corcept Therapeutics Incorporated - Common Stock | 118.54 USD | -0.89% | +3.96% | +3.80% | +61.56% | 12.81 B USD | ||
| 766 |  BBIO BridgeBio Pharma, Inc. - Common Stock | 65.04 USD | -2.20% | -2.79% | -11.67% | +14.11% | 12.71 B USD | ||
| 778 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 109.86 USD | -0.84% | +2.73% | +2.20% | +64.46% | 12.47 B USD | ||
| 822 |  TECH Bio-Techne Corp - Common Stock | 72.47 USD | -0.08% | +0.08% | +0.24% | +19.67% | 11.36 B USD |
Noticias Biotechnology Stocks
Raymond James inicia cobertura de Kymera Therapeutics con Mejor Rendimiento
Raymond James inicia cobertura de Nektar con calificación de rendimiento de mercado
Palisade Bio inicia cobertura con Mejor Rendimiento según Raymond James
Raymond James reitera su calificación de Liquidia en medio de presentaciones legales
Tenax Therapeutics pausa temporalmente la inscripción en el ensayo LEVEL-2 de TNX-103 para modificar los criterios; solicita reunión con la FDA
Ginkgo Bioworks apoyará a los X-Labs de la NSF con acceso a su laboratorio
AbCellera presentará datos de fase 1/2 sobre su candidato para la menopausia
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |